4DMedical (ASX:4DX) logged a AU$0.03 loss per share for fiscal 2026, compared with a loss of AU$0.14 a year ago, a Friday filing showed.
For the 12 months ended June 30, revenue was AU$7.1 million versus AU$5.9 million previously, the Australia-listed medical technology company added.
Its shares gained 3% in recent Friday trade.